首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >Transcriptional and post-transcriptional regulation of transmembrane protein 132A
【24h】

Transcriptional and post-transcriptional regulation of transmembrane protein 132A

机译:跨膜蛋白132a的转录和转录后调节

获取原文
获取原文并翻译 | 示例
       

摘要

Transmembrane protein 132A (TMEM132A) was first isolated from rat brain using PCR-selected cDNA subtraction, and it was found to be predominantly expressed in the brain. However, the transcriptional regulation of the TMEM132A gene has not been fully characterized. In this study, we characterized the promoter activity of the 880-bp region upstream of the mouse TMEM132A, identifying several putative sites recognized by transcription factors, which are highly conserved between the mouse and human TMEM132A genes. Using four different mouse cell lines (Neuro2a, NSC-34, NIH3T3, and Raw264.7), we first evaluated the intrinsic levels of TMEM132A mRNA and protein expression. Interestingly, TMEM132A mRNA was expressed in all four cell lines, whereas the protein was negligible in Raw264.7 cells even by transfection of TMEM132A gene. Then, we analyzed the TMEM132A promoter activity using serial deleted constructs, finding it was nearly same pattern in all four cell lines. A mutational analysis of the TMEM132A promoter identified a critical region for its activation just upstream of the transcriptional start site. Finally, we investigated the levels of TMEM132A mRNA and protein after exposure to five different neurotoxic stimuli, including thapsigargin, tunicamycin, serum starvation, homocysteine, and hydrogen peroxide. Treatment with thapsigargin, a calcium modulating agent, markedly attenuated the levels of TMEM132A mRNA and protein in NSC-34 cells. These results give new insight into the mechanisms involved in regulating TMEM132A expression, and suggest that several transcriptional and post-transcriptional pathways regulate TMEM132A expression under developmental and pathophysiological conditions.
机译:使用PCR选择的cDNA减法首先从大鼠脑中分离跨膜蛋白132a(tmem132a),发现它主要在大脑中表达。然而,TME132A基因的转录调节尚未完全表征。在该研究中,我们表征了小鼠TMEM132A上游的880-BP区域的启动子活性,鉴定了通过转录因子认识到的若干推定位点,其在小鼠和人TMEM132A基因之间高度保守。使用四种不同的小鼠细胞系(Neuro2a,Nsc-34,NiH3T3和Raw264.7),首先评估TMEM132A mRNA和蛋白质表达的内在水平。有趣的是,TMEM132A mRNA在所有四种细胞系中表达,而植物在RAW264.7细胞中甚至可以忽略不计,甚至通过TMEM132A基因转染。然后,我们使用连续缺失的构建体分析TMEM132A启动子活性,发现所有四个细胞系中的图案几乎相同。 TMEM132A启动子的突变分析鉴定了其在转录起始位点上游的活化的关键区域。最后,我们研究了暴露于五种不同神经毒性刺激后TMEM132A mRNA和蛋白的水平,包括Thapsigargin,Tunicamycin,血清饥饿,同型半胱氨酸和过氧化氢。用ThapsIgargin,钙调节剂处理,显着衰减了NSC-34细胞中TMEM132a mRNA和蛋白质的水平。这些结果对调节TMEM132A表达的机制提供了新的洞察力,并表明了几种转录和转录后途径调节发育和病理生理病症下的TMEM132A表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号